News

This article describes common misconceptions about treatment of psychiatric illness during pregnancy and advocates for a logical and thoughtful approach to designing a treatment plan.

Based on recent data, it is looking more and more like the answer may be that social media is not particularly beneficial for most of us.

OCD symptoms can be quite difficult to recognize. Not understanding what is happening, patients tend to be ashamed and suffer in silence, often resulting in a period of 8 to 10 years of untreated illness and long-term negative outcomes.

There are people who insist the one-hour change causes havoc on their systems and schedules. Is there any scientific foundation to this claim? Let us examine some common questions, concerns, and myths.

Recently, the use of spectral-domain optical coherence tomography has contributed to our understanding of retinal abnormalities in schizophrenia.

Information on minimum and maximum effective doses has great clinical utility, and new findings provide guidance.

How have the pharmaceutical industry and academic guild interests shaped the evolution of psychiatry? Lisa Cosgrove, PhD, has something to say about it.

Pseudopatients and their discontents: an historical perspective.

When we meet a new patient who presents with "classic" symptoms, there are challenges described in this brief video.

What can psychiatrists in the US do to better prepare themselves and their patients for potential natural disasters? A research psychiatrist answers that question and more in this Psychiatric Times exclusive.

After receiving complaints, the FDA’s Office of Prescription Drug Promotion rebukes the pharmaceutical company for misleading advertising.

Chronotherapy presents a unique tool to add to the armamentarium of available modalities for management of non-seasonal depression. Clinicians should be familiar with its application and be able to implement it in recalcitrant sufferers.

The FDA accepts a New Drug Application for novel antidepressant.

This review highlights an important diagnostic and therapeutic task: the importance of differentiating true bipolar disorder/obsessive-compulsive disorder comorbidity from BD with secondary OCD.

Although the current generation of antidepressants extends back to the late 1980s, efforts to describe the dose-response relationship for treatment of major depressive disorder continue. More in this research update.

High traditional masculinity (HTM) men are more likely to die by suicide than non-HTM men, but they are less likely to report suicide ideation.

Depression, suicidal ideation, self-harming behaviors, and anxiety, as well as lower reaction time and cognitive decline, were found in patients with celiac disease, according to a recent study

Despite heterogeneity in symptoms, there is growing realization that common neurobiological processes may contribute to OCD vulnerability and its persistence.

The articles in this Special Report focus on the interplay between trauma and its consequences, including violent behaviors, substance use disorders, and stroke. Taken together, the articles may contribute to a better understanding of-and treatment development for-patients exposed to trauma.

Ultimately, the decision about involuntary treatment is about risk, not predictable outcomes. In many cases, however, these decisions are much more difficult and, until our crystal balls arrive, our best efforts may still fall short.

Psychotic violence is associated with primary psychotic disorders such as schizophrenia, schizoaffective disorder, and bipolar disorder. While it may be that psychotic violence is the least common type of violence in inpatient environments, it is also the most treatable.

The goals of psychotherapy education in medical school should be based on these seven ideals.

We often hear about seasonal affective disorder, but we don’t talk much about “winter woes.” Amaryllis offers something for everyone, for it encourages celebrations on many occasions, over as many months.

This generation of young people may have a unique risk of exposure to stress and researchers and clinicians are increasingly concerned about the long-term health consequences of such chronic exposure for young adults.

When we find ourselves in the half-tested world of off-label therapies, what’s a psychiatrist to do?

Over the past two decades, deaths associated with alcohol abuse have increased, but little data point to demographic changes.

My hacker stole my identity crisis.

Access to care has improved-especially for low-income and vulnerable populations-which has resulted in better health outcomes.

Drug companies are investing more to study psychiatric disorders, and there may be novel treatments in the near future.

A hypothetical first conversation with a non-binary person . . . One of us would be feeling nervous and the other certain-a phenomenon not unfamiliar to a psychiatrist, only here the roles would be reversed.